Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> First-Ever Cases of Marburg Virus Disease Reported in Ghana 08/07/2022 Editorial team Ghana has reported two suspected cases of the rare and deadly Marburg virus disease – the first to ever be recorded within its borders. Marburg is a highly infectious viral haemorrhagic fever in the same family as the more well-known Ebola virus disease, said WHO’s Ghana Country Office in making the announcement. It has a […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> DRC Declares End of 14th Ebola Outbreak -Vaccinations Reduced Deadly Virus Toll 04/07/2022 Editorial team The Ebola outbreak that erupted on 23 April in the Democratic Republic of the Congo today was declared to be over by DRC and WHO authorities – with fewer cases and deaths than previous episodes thanks to a swift response including vaccinations. The outbreak erupted in Mbandaka, the capital of Equateur Province in the country’s […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Sets Up Hub in Nairobi to Address East Africa Malnutrition Crisis 30/06/2022 Kerry Cullinan In the face of growing malnutrition and related diseases of pneumonia, diarrhoea and measles, the World Health Organization (WHO) has announced that it is setting up a hub in Kenya to help fight the “major physical and mental health repercussions” of the food crisis in the Eastern Africa region. More than 80 million people, or […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> WHO Will Reconsider Declaring Monkeypox a Health Emergency in 21 Days – If Certain Criteria Are Met 27/06/2022 Kerry Cullinan Although the World Health Organization (WHO) has decided not to declare monkeypox a public health emergency of international concern (PHEIC), it could change its mind if there is evidence of “significant spread” in the next 21 days. This was announced over the weekend following the meeting of the WHO’s International Health Regulations (IHR) Emergency […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
First-Ever Cases of Marburg Virus Disease Reported in Ghana 08/07/2022 Editorial team Ghana has reported two suspected cases of the rare and deadly Marburg virus disease – the first to ever be recorded within its borders. Marburg is a highly infectious viral haemorrhagic fever in the same family as the more well-known Ebola virus disease, said WHO’s Ghana Country Office in making the announcement. It has a […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> DRC Declares End of 14th Ebola Outbreak -Vaccinations Reduced Deadly Virus Toll 04/07/2022 Editorial team The Ebola outbreak that erupted on 23 April in the Democratic Republic of the Congo today was declared to be over by DRC and WHO authorities – with fewer cases and deaths than previous episodes thanks to a swift response including vaccinations. The outbreak erupted in Mbandaka, the capital of Equateur Province in the country’s […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Sets Up Hub in Nairobi to Address East Africa Malnutrition Crisis 30/06/2022 Kerry Cullinan In the face of growing malnutrition and related diseases of pneumonia, diarrhoea and measles, the World Health Organization (WHO) has announced that it is setting up a hub in Kenya to help fight the “major physical and mental health repercussions” of the food crisis in the Eastern Africa region. More than 80 million people, or […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> WHO Will Reconsider Declaring Monkeypox a Health Emergency in 21 Days – If Certain Criteria Are Met 27/06/2022 Kerry Cullinan Although the World Health Organization (WHO) has decided not to declare monkeypox a public health emergency of international concern (PHEIC), it could change its mind if there is evidence of “significant spread” in the next 21 days. This was announced over the weekend following the meeting of the WHO’s International Health Regulations (IHR) Emergency […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> DRC Declares End of 14th Ebola Outbreak -Vaccinations Reduced Deadly Virus Toll 04/07/2022 Editorial team The Ebola outbreak that erupted on 23 April in the Democratic Republic of the Congo today was declared to be over by DRC and WHO authorities – with fewer cases and deaths than previous episodes thanks to a swift response including vaccinations. The outbreak erupted in Mbandaka, the capital of Equateur Province in the country’s […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Sets Up Hub in Nairobi to Address East Africa Malnutrition Crisis 30/06/2022 Kerry Cullinan In the face of growing malnutrition and related diseases of pneumonia, diarrhoea and measles, the World Health Organization (WHO) has announced that it is setting up a hub in Kenya to help fight the “major physical and mental health repercussions” of the food crisis in the Eastern Africa region. More than 80 million people, or […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> WHO Will Reconsider Declaring Monkeypox a Health Emergency in 21 Days – If Certain Criteria Are Met 27/06/2022 Kerry Cullinan Although the World Health Organization (WHO) has decided not to declare monkeypox a public health emergency of international concern (PHEIC), it could change its mind if there is evidence of “significant spread” in the next 21 days. This was announced over the weekend following the meeting of the WHO’s International Health Regulations (IHR) Emergency […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
DRC Declares End of 14th Ebola Outbreak -Vaccinations Reduced Deadly Virus Toll 04/07/2022 Editorial team The Ebola outbreak that erupted on 23 April in the Democratic Republic of the Congo today was declared to be over by DRC and WHO authorities – with fewer cases and deaths than previous episodes thanks to a swift response including vaccinations. The outbreak erupted in Mbandaka, the capital of Equateur Province in the country’s […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Sets Up Hub in Nairobi to Address East Africa Malnutrition Crisis 30/06/2022 Kerry Cullinan In the face of growing malnutrition and related diseases of pneumonia, diarrhoea and measles, the World Health Organization (WHO) has announced that it is setting up a hub in Kenya to help fight the “major physical and mental health repercussions” of the food crisis in the Eastern Africa region. More than 80 million people, or […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> WHO Will Reconsider Declaring Monkeypox a Health Emergency in 21 Days – If Certain Criteria Are Met 27/06/2022 Kerry Cullinan Although the World Health Organization (WHO) has decided not to declare monkeypox a public health emergency of international concern (PHEIC), it could change its mind if there is evidence of “significant spread” in the next 21 days. This was announced over the weekend following the meeting of the WHO’s International Health Regulations (IHR) Emergency […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Sets Up Hub in Nairobi to Address East Africa Malnutrition Crisis 30/06/2022 Kerry Cullinan In the face of growing malnutrition and related diseases of pneumonia, diarrhoea and measles, the World Health Organization (WHO) has announced that it is setting up a hub in Kenya to help fight the “major physical and mental health repercussions” of the food crisis in the Eastern Africa region. More than 80 million people, or […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> WHO Will Reconsider Declaring Monkeypox a Health Emergency in 21 Days – If Certain Criteria Are Met 27/06/2022 Kerry Cullinan Although the World Health Organization (WHO) has decided not to declare monkeypox a public health emergency of international concern (PHEIC), it could change its mind if there is evidence of “significant spread” in the next 21 days. This was announced over the weekend following the meeting of the WHO’s International Health Regulations (IHR) Emergency […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Sets Up Hub in Nairobi to Address East Africa Malnutrition Crisis 30/06/2022 Kerry Cullinan In the face of growing malnutrition and related diseases of pneumonia, diarrhoea and measles, the World Health Organization (WHO) has announced that it is setting up a hub in Kenya to help fight the “major physical and mental health repercussions” of the food crisis in the Eastern Africa region. More than 80 million people, or […] Continue reading -> European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> WHO Will Reconsider Declaring Monkeypox a Health Emergency in 21 Days – If Certain Criteria Are Met 27/06/2022 Kerry Cullinan Although the World Health Organization (WHO) has decided not to declare monkeypox a public health emergency of international concern (PHEIC), it could change its mind if there is evidence of “significant spread” in the next 21 days. This was announced over the weekend following the meeting of the WHO’s International Health Regulations (IHR) Emergency […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency Considers Extension of Smallpox Vaccine Use for Monkeypox 28/06/2022 Elaine Ruth Fletcher The European Medicines Agency is considering the extension of the use of the smallpox vaccine Imvanex to include people at risk of Monkeypox disease, the agency said on Tuesday. Imvanex is a modified form of the vaccinia virus, which is related to smallpox and currently authorised in the European Union (EU) for the prevention of […] Continue reading -> Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> WHO Will Reconsider Declaring Monkeypox a Health Emergency in 21 Days – If Certain Criteria Are Met 27/06/2022 Kerry Cullinan Although the World Health Organization (WHO) has decided not to declare monkeypox a public health emergency of international concern (PHEIC), it could change its mind if there is evidence of “significant spread” in the next 21 days. This was announced over the weekend following the meeting of the WHO’s International Health Regulations (IHR) Emergency […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> WHO Will Reconsider Declaring Monkeypox a Health Emergency in 21 Days – If Certain Criteria Are Met 27/06/2022 Kerry Cullinan Although the World Health Organization (WHO) has decided not to declare monkeypox a public health emergency of international concern (PHEIC), it could change its mind if there is evidence of “significant spread” in the next 21 days. This was announced over the weekend following the meeting of the WHO’s International Health Regulations (IHR) Emergency […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Will Reconsider Declaring Monkeypox a Health Emergency in 21 Days – If Certain Criteria Are Met 27/06/2022 Kerry Cullinan Although the World Health Organization (WHO) has decided not to declare monkeypox a public health emergency of international concern (PHEIC), it could change its mind if there is evidence of “significant spread” in the next 21 days. This was announced over the weekend following the meeting of the WHO’s International Health Regulations (IHR) Emergency […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> Posts navigation Older postsNewer posts